This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.
Picture a founder three years into a C corporation, holding stock that checks every qualified small business stock box, staring at an acquisition offer too good to refuse. The § 1202 exclusion — the one that could make millions of dollars of gain disappear from the federal return — needs more holding period than the deal timeline allows. The conventional reading of that situation is a lament: sell now and lose the exclusion, or gamble on the buyer still being there in two years. The conventional reading skips a section of the Code. Section 1045 exists for exactly this founder, and it does something almost no other provision does: it lets you sell now and keep building the same holding period in a different company’s stock.
Section 1202 rewards patience, and § 1045 lets you buy patience
The one-sentence refresher: § 1202 excludes some or all of the gain on qualified small business stock — original-issuance C corporation stock in a qualifying small business — once the holding period clears the statutory threshold, a regime we mapped in our post on the post-OBBBA § 1202 tiers and what they mean for a founder sale. The exclusion is the headline act of founder tax planning, and its Achilles’ heel has always been timing: acquisition offers do not schedule themselves around your stock certificate’s birthday.
Section 1045 is the pressure valve. A taxpayer other than a corporation who sells QSBS held for more than six months may elect to defer the gain by purchasing replacement QSBS within sixty days. The statutory formula runs on cost: gain is recognized only to the extent the amount realized exceeds the cost of qualified small business stock purchased, in the statute’s words, “during the 60-day period beginning on the date of such sale.” Reinvest the full proceeds into new QSBS and recognize nothing now; reinvest half and recognize the other half. It is a rollover in the honest sense — the tax bill doesn’t vanish, it moves.
Where does it move? Into basis. Under § 1045(b)(3), the deferred gain reduces the basis of the replacement stock, in the order acquired. Sell for $3 million with a near-zero basis, roll the whole amount into a new qualifying company, and your replacement stock carries a basis stripped down by the deferred gain. If the replacement stock later fails to reach § 1202 nirvana, the deferred gain comes home. If it does reach the threshold, the story gets much better, which is the next point.
The holding period tacks, and that is the whole game
A deferral, by itself, is a decent trade. What elevates § 1045 from decent to strategic is the holding-period treatment: through the tacking rules of § 1223, the holding period of the original QSBS carries over to the replacement QSBS for purposes of the § 1202 clock. The founder who sold at year three is not starting over at the new company — they arrive holding stock with three years already on the odometer. Two more years in the replacement position and the combined holding period can carry the deferred gain, plus the replacement stock’s own appreciation, into exclusion territory, subject to the per-issuer caps and the rest of § 1202’s machinery.
The statute polices the obvious games. The sold stock must itself have been held more than six months — measured, per § 1045(b)(4), without tacking — so there is no rapid-fire laundering of fresh stock through serial sales. And the statute eases a test that would otherwise be impossible for the replacement company: only the first six months of the replacement holding period are tested for § 1202(c)(2)’s active-business requirement, since no investor can guarantee what a portfolio company will look like in year four. Note, too, the formula’s small print in § 1045(a)(2): replacement cost is reduced by amounts previously counted under the section, which keeps one dollar of new stock from sheltering two dollars of gain, while still permitting genuine serial rollovers — sell, roll, the new company itself exits early, roll again — with the holding period accumulating across the chain.
One more structural note: the rollover is not an individuals-only tool. The section applies to taxpayers other than corporations, and the regulations at Treas. Reg. § 1.1045-1 work through partnership mechanics — a fund or founder-holding LLC taxed as a partnership can navigate a rollover, with the usual pass-through complexity deserving its own analysis before anyone relies on it.
Your PE rollover is probably not a § 1045 rollover
Here is the misconception most worth killing. Founders hear “rollover” and picture the familiar private equity structure — sell eighty percent for cash, roll twenty percent into the buyer’s holding company, the structure we’ve dissected in posts on rollover equity and the 83(b) election and the F-reorg rollover with a PE buyer. That rollover and the § 1045 rollover share a word and nothing else.
Replacement stock under § 1045 must be qualified small business stock in its own right, which drags in all of § 1202(c): stock in a domestic C corporation, acquired at original issuance, in a corporation that satisfies the gross-asset ceiling and the active-business requirement. Measure the typical PE rollover against that list and it fails at almost every step. Rolling into the sponsor’s holding company usually means acquiring interests in an LLC taxed as a partnership — not C corporation stock. Even where the topco is a corporation, its aggregate gross assets after the platform acquisition routinely blow through the ceiling, and a holding-company structure can flunk the active-business test besides. The realistic § 1045 universe is different: writing original-issuance checks into new or early-stage C corporations — the founder’s next startup, angel positions in someone else’s, a syndicate allocation — within sixty days of the sale. A founder who wants both the PE rollover economics and a § 1045 deferral on the cash portion is running two separate analyses that happen to share a closing date.
Sixty days meets real deal mechanics, and real deal mechanics are messy
The window is the discipline. Sixty days runs from the date of sale — a date the founder does not fully control once signing-to-closing gaps, escrows, and earnouts enter the picture. The clean planning posture is to treat the § 1045 decision as a pre-closing workstream: know before the wire hits whether replacement investments are wanted, which targets qualify, and how much of the proceeds they can absorb. Founders who start sourcing qualifying investments after closing are spending their sixty days on diligence they could have finished during the buyer’s.
Deferred and contingent consideration deserves particular respect. Purchase price that arrives over time — escrow releases, earnout payments, installment notes — raises genuinely technical questions about how much gain is eligible and when reinvestment must happen, and the interaction with installment-sale rules has traps of its own, in the same neighborhood as the ones we cataloged for large installment obligations under § 453A. The election itself is made on a timely filed return for the year of sale, which means the founder’s deal counsel and tax preparer need to be talking to each other in the sale year, not at the following April’s intake meeting.
For a Florida founder the arithmetic has a familiar kicker: with no state income tax on the individual side, the federal treatment is the whole ballgame, so a successful defer-then-exclude sequence can convert a taxable exit into something close to a tax-free one. The likely outcome for a well-advised founder selling early is not the lament from the opening paragraph — it is a checklist: confirm the sold stock’s QSBS pedigree, decide how much gain to roll, source original-issuance replacement positions inside the window, elect properly, and let the tacked holding period finish the job the deal timeline interrupted.
If you are selling QSBS before the § 1202 holding period is met, or planning the reinvestment side of an early exit, feel free to reach out to our firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.
